Emily O’Neill
Impact in
- Hepatology top 10%
- Liver physiology and pathology
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Antibiotic Use and Resistance 3
-
- Antibiotic Resistance in Bacteria 2
Emily O’Neill
9 papers receiving 609 citations
Peers
Comparison fields: 5 of 94
- Hepatology 114
- Pharmacology 115
- Immunology 188
- Rehabilitation 44
- Epidemiology 158
Countries citing papers authored by Emily O’Neill
This map shows the geographic impact of Emily O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily O’Neill more than expected).
Fields of papers citing papers by Emily O’Neill
This network shows the impact of papers produced by Emily O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily O’Neill. The network helps show where Emily O’Neill may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily O’Neill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 7 | |
| 8 | 2020 | 55 | |
| 9 | 2017 | 57 | |
| 10 | 2013 | 20 | |
| 11 | 2010 | 20 | |
| 12 | 2009 | 10 | |
| 13 | 1994 | 453 |
About Emily O’Neill
Emily O’Neill is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Internal Medicine, Pharmacology and Endocrinology, having authored 13 papers that have together received 624 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (3 papers), Computational Drug Discovery Methods (2 papers), Antibiotic Resistance in Bacteria (2 papers), Obstructive Sleep Apnea Research (2 papers), Immunotoxicology and immune responses (1 paper), Analytical chemistry methods development (1 paper), Vibrio bacteria research studies (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Hepatology (114 citations), Pharmacology (115 citations), Immunology (188 citations), Rehabilitation (44 citations) and Epidemiology (158 citations). Emily O’Neill has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Hidekazu Mizuhara, H Fujiwara, H Senoh, K. Otsuka, Nobuo Seki, Mineo Niwa, S Satoh, T Ogawa, James L. Rudolph and Michelle Lally. Their work appears in journals such as Toxicologic Pathology, Journal of the American Medical Directors Association, Journal of Sleep Research, BMJ Global Health and Analytical and Bioanalytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.